J7627 – Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg

Long description

Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg

Short description

Budesonide comp unit

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

D1G Drugs Administered through DME

Added

January 1, 2006

Last change

January 1, 2007 – No change

Nearby J codes

• J7612 – Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
• J7613 – Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
• J7614 – Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
• J7615 – Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
• J7620 – Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
• J7622 – Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7624 – Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7626 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
• J7628 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7629 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7631 – Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
• J7632 – Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
• J7633 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
• J7634 – Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
• J7635 – Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7636 – Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram